Voluntary announcement in relation to the application for compulsory enforcement by a wholly-owned subsidiary in respect of the shareholders' right to information of beijing kangchen biological technology co., limited
Filed with HKEX · Stock code 1011 · · 3 pages · English
(Incorporated in the Cayman Islands with limited liability) (Stock Code: 1011) VOLUNTARY ANNOUNCEMENT IN RELATION TO THE APPLICATION FOR COMPULSORY ENFORCEMENT BY A WHOLLY-OWNED SUBSIDIARY IN RESPECT OF THE SHAREHOLDERS’ RIGHT TO INFORMATION OF BEIJING KANGCHEN BIOLOGICAL TECHNOLOGY CO., LIMITED This announcement is made by China NT Pharma Group Company Limited (the "Company" together with its sub
China NT Pharma Group Co., Ltd. on 6ix
Earlier from China NT Pharma
- Inside information announcement arbitration award
- Appointment of auditor
- Connected transaction in relation to loan capitalisation involving subscription of shares under Specific mandate
- Supplemental announcement retirement of auditor
- China NT Pharma Group: Proposed granting of general mandates to issue shares and repurchase shares, proposed re-election of retiring directors and notice of annual general meeting
Later from China NT Pharma
- 2026 Interim Report
- Notification Letter and Reply Form to Registered Shareholder
- Notification Letter and Request Form to Non-Registered Holder
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Appointment of auditor and notice of extraordinary general meeting
Follow China NT Pharma into a list and get an email when it puts out news.
Follow China NT Pharma